30/12/2022 |
Application for quotation of securities |
09/12/2022 |
Corporate Update and Acquisition |
29/11/2022 |
Amended Constitution |
29/11/2022 |
CEO’s AGM Address |
29/11/2022 |
Final Directors Interest Notice – Eck |
29/11/2022 |
Results of Annual General Meeting |
28/10/2022 |
Notice of Annual General Meeting/Proxy Form |
26/10/2022 |
Appendix 4C and Quarterly Activity Report |
17/10/2022 |
Director Resignation – Dennis Eck |
23/09/2022 |
Annual Report to Shareholders |
23/09/2022 |
Appendix 4G and Corporate Governance Statement |
16/09/2022 |
Change of Director’s Interest Notice – Greasley |
25/08/2022 |
Appendix 4E and FY22 Financial Report |
26/07/2022 |
Advangen Japan Divestment and Earn-Out Agreement |
26/07/2022 |
Appendix 4C and Quarterly Activity Report |
08/07/2022 |
Appointment of Exec Director, Corporate and Trading Update |
08/07/2022 |
Initial Director’s Interest Notice – Greasley |
28/04/2022 |
Appendix 4C and Quarterly Activity Report |
16/03/2022 |
New Leadership Driving Business Transformation |
02/03/2022 |
Notification of cessation of securities – AN1 |
01/03/2022 |
Anagenics Appoints CEO |
01/03/2022 |
Final Director’s Interest Notice – Halasz |
15/02/2022 |
Anagenics Board and Leadership Transition |
15/02/2022 |
Appendix 4D and Half Year Report |
15/02/2022 |
Final Director’s Interest Notice – Gordon |
15/02/2022 |
Initial Director’s Interest Notice – Beard |
02/02/2022 |
Change of Director’s Interest Notice – Halasz |
28/01/2022 |
Appendix 4C and Quarterly Activity Report |
20/01/2022 |
Change in substantial holding from HNG |
07/01/2022 |
Application for quotation of securities – AN1 |
07/01/2022 |
Change of Director’s Interest Notice – DE |
07/01/2022 |
Cleansing Notice |
07/01/2022 |
Release of Shares from Voluntary Escrow |